The lumbar artificial disc (LAD) market has experienced significantly lower procedural growth than other market segments as a result of a lack in clinical efficacy data and poor reimbursement. In 2014, the reimbursement environment severely limited the number of LAD procedures performed. However, reimbursement policies are expected to change because Medicare and other organizations are considering reimbursement for newer LADs.
Is the Lumbar total disc replacement (TDR) Back?
Many LAD products that are approved for use in Europe have historically performed well because they tend to have fewer risks and complications than DePuy’s Charité, the first (and previously, the only) LAD device available in the U.S. market. As clinical data continues to emerge and new products are introduced to the market, the LAD segment is expected to stabilize over the next five years. Lumbar artificial disc sold over USD 240 million for 2015. It has become the most preferred treatment option among patients with severe back pain. In 2017, during the NASS Annual Meeting in Orlando, FL, many key presentations were focused on the support of lumbar total disc replacement (TDR) as a standard of care for a subpopulation of patients suffering from degenerative disc disease (DDD). The U.S. artificial disc market looks set to surpass USD 2 billion by 2024, which translates to over 20% growth. Increasing healthcare expenditure, favorable reimbursement policy structure, growing disposable income and higher success rate of artificial disc replacements should stimulate business growth.
Which are the trends for Lumbar total disc replacement (TDR) according to Global Market Insights, Inc.?
- Increasing prevalence of degenerative disc diseases and growing trend towards noninvasive medical interventions will stimulate artificial disc market growth. Reduction in re-operation rate compared to other fusion methods will also assist industry expansion.
- Technological innovation and new product development will create effective treatment options in artificial disc replacement market space. Improvement in artificial disc clinical trial results have resulted into increased demand among surgeon’s and patients. Lack of uniform and adequate reimbursement, high procedure cost and expensive devices should hamper artificial disc market growth over the forecast period.
- Metal on biopolymer has seen significant gains, with expectations to exceed USD 4 billion by 2024. Flexible PU/ PE allows better motion and shock absorption. Metal on polyethylene device makes the insertion of the device easier and is the device of choice for surgeons. Metal on Metal artificial disc should witness over 20% CAGR over forecast period. The rising demand for cost-effective artificial disc in emerging nations should propel segment growth.
Which are the 10 main players? Please visit: https://thespinemarketgroup.com/category/adl/